Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Palivizumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AstraZeneca to launch Palivizumab (Synagis) in India
    AstraZeneca to launch Palivizumab (Synagis) in India

    19 Sep 2024

    // EXPRESSPHARMA

    https://www.expresspharma.in/astrazeneca-to-launch-palivizumab-synagis-in-india/

    EXPRESSPHARMA
    19 Sep 2024
    Share Share
    AstraZeneca India gets permission to import Palivizumab solution for injection
    AstraZeneca India gets permission to import Palivizumab solution for injection

    03 Oct 2023

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/astrazeneca-pharma-india-gets-permission-to-import-palivizumab-solution-for-injection-14737

    INDIAN PHARMA POST
    03 Oct 2023
    Share Share
    UK signs off on Sanofi, AstraZeneca's RSV antibody four days after Europe
    UK signs off on Sanofi, AstraZeneca's RSV antibody four days after Europe

    10 Nov 2022

    // Paul Schloesser ENDPTS

    https://endpts.com/uk-signs-off-on-sanofi-astrazenecas-rsv-antibody-four-days-after-europe/

    Paul Schloesser ENDPTS
    10 Nov 2022
    Share Share
    Enanta paves way for mid-stage RSV study in adult patients later this year
    Enanta paves way for mid-stage RSV study in adult patients later this year

    17 Jun 2019

    // Natalie Grover ENDPTS

    https://endpts.com/fueled-by-early-success-enanta-paves-way-for-mid-stage-rsv-study-in-adult-patients-later-this-year/

    Natalie Grover ENDPTS
    17 Jun 2019
    Share Share